Skip to content

Mechanisms Contributing to Cognitive Deficits in Cannabis Users

Romina Mizrahi, Jeremy J. Watts, Kuei Yuan Tseng

Neuropharmacology April 14, 2017 DOI: 10.1016/j.neuropharm.2017.04.018 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Topics Cannabis
Key findings Argues that sustained CB1 receptor activation, based largely on preclinical animal models, is a major contributing factor to cognitive deficits associated with chronic cannabis use, especially in working memory and decision-making, while noting that few studies have directly assessed CB1 receptors' role in human brain function.

Abstract

Studies from preclinical animal models indicate that sustained activation of CB1 receptor signaling is a major contributing factor for the onset of cognitive deficits associated to chronic cannabis use, in particular within the working memory and decision-making domains. Yet, very few studies have been designed to directly assess the role of CB1 receptors in mediating the effects of cannabis on human brain function. This perspective review article provides an overview of current state of knowledge on possible neurobiological mechanisms accounting for the detrimental effects of chronic cannabis use on cognition and related changes in brain structure and functional connectivity.

Comparable studies

Other narrative reviews on cannabis, most cited first.

Citations in the library

Explore topics